These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1409562)

  • 1. Modeling of substrate and inhibitor binding to phospholipase A2.
    Sessions RB; Dauber-Osguthorpe P; Campbell MM; Osguthorpe DJ
    Proteins; 1992 Sep; 14(1):45-64. PubMed ID: 1409562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation of a phospholipase A2-substrate complex.
    Jones ST; Ahlström P; Berendsen HJ; Pickersgill RW
    Biochim Biophys Acta; 1993 Mar; 1162(1-2):135-42. PubMed ID: 8448177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex.
    Bennion C; Connolly S; Gensmantel NP; Hallam C; Jackson CG; Primrose WU; Roberts GC; Robinson DH; Slaich PK
    J Med Chem; 1992 Aug; 35(16):2939-51. PubMed ID: 1501221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate binding and catalytic mechanism in phospholipase C from Bacillus cereus: a molecular mechanics and molecular dynamics study.
    da Graça Thrige D; Buur JR; Jørgensen FS
    Biopolymers; 1997 Sep; 42(3):319-36. PubMed ID: 9279125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular dynamics study of the three-dimensional model of human synovial fluid phospholipase A2--transition state mimic complexes.
    Hariprasad V; Kulkarni VM
    J Mol Recognit; 1996; 9(2):95-102. PubMed ID: 8877799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Asp-49 and other conserved amino acids in phospholipases A2 and their importance for enzymatic activity.
    van den Bergh CJ; Slotboom AJ; Verheij HM; de Haas GH
    J Cell Biochem; 1989 Apr; 39(4):379-90. PubMed ID: 2722967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles.
    Salgo MG; Corongiu FP; Sevanian A
    Arch Biochem Biophys; 1993 Jul; 304(1):123-32. PubMed ID: 8323278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling in the design of phospholipase A2 inhibitors.
    Ripka WC; Sipio WJ; Galbraith WG
    J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2 activity and physical properties of lipid-bilayer substrates.
    Hønger T; Jørgensen K; Stokes D; Biltonen RL; Mouritsen OG
    Methods Enzymol; 1997; 286():168-90. PubMed ID: 9309651
    [No Abstract]   [Full Text] [Related]  

  • 11. X-ray crystal structure and molecular dynamics simulation of bovine pancreas phospholipase A2-n-dodecylphosphorylcholine complex.
    Tomoo K; Ohishi H; Ishida T; Inoue M; Ikeda K; Sumiya S; Kitamura K
    Proteins; 1994 Aug; 19(4):330-9. PubMed ID: 7984628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors.
    Magolda RL; Galbraith W
    J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Properties of phospholipase A2 from the venom of the large hornet Vespa orientalis].
    Tuĭchibaev MU; Iakubov IT; Rakhimov MM; Tashmukhamedov BA
    Biokhimiia; 1984 Sep; 49(9):1546-55. PubMed ID: 6518194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The electrostatic basis for the interfacial binding of secretory phospholipases A2.
    Scott DL; Mandel AM; Sigler PB; Honig B
    Biophys J; 1994 Aug; 67(2):493-504. PubMed ID: 7948668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of an engineered porcine phospholipase A2 with enhanced activity at 2.1 A resolution. Comparison with the wild-type porcine and Crotalus atrox phospholipase A2.
    Thunnissen MM; Kalk KH; Drenth J; Dijkstra BW
    J Mol Biol; 1990 Nov; 216(2):425-39. PubMed ID: 2254938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
    Scott DL; White SP; Browning JL; Rosa JJ; Gelb MH; Sigler PB
    Science; 1991 Nov; 254(5034):1007-10. PubMed ID: 1948070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of phospholipase A2-ligand interactions.
    Biltonen RL; Lathrop BK; Bell JD
    Methods Enzymol; 1991; 197():234-48. PubMed ID: 2051917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation, aggregation, inhibition and the mechanism of phospholipase A2.
    Hazlett TL; Deems RA; Dennis EA
    Adv Exp Med Biol; 1990; 279():49-64. PubMed ID: 2096700
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative anatomy of phospholipase A2 structures.
    Ward KB; Pattabiraman N
    Adv Exp Med Biol; 1990; 279():23-36. PubMed ID: 2096696
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of drug binding affinities by comparative binding energy analysis.
    Ortiz AR; Pisabarro MT; Gago F; Wade RC
    J Med Chem; 1995 Jul; 38(14):2681-91. PubMed ID: 7629807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.